文献速递肝病

自身免疫性肝炎与维生素D缺乏:全国性视角

Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective.
PubMed 文献 · Aliment Pharmacol Ther · 2024-12-11

基于TriNetX网络的回顾性队列研究,将1288例维生素D缺乏的自身免疫性肝炎患者与1288例维生素D正常者经倾向评分匹配后比较。维生素D缺乏组全因死亡、全因住院、重症监护入院、失代偿性肝硬化、急性肝衰竭及肝移植的比值均显著升高。

要点

  • 维生素D缺乏的自身免疫性肝炎患者全因死亡风险升高(aOR=3.2)。
  • 维生素D缺乏与全因住院、重症监护入院、失代偿性肝硬化、急性肝衰竭及肝移植风险升高相关。
  • 研究为回顾性队列设计,结果需结合原文局限性解读。

核心结论

  • 本队列研究显示,维生素D缺乏的自身免疫性肝炎患者全因死亡比值显著升高。
  • 维生素D缺乏与住院、失代偿性肝硬化、急性肝衰竭及肝移植可能性增加相关。

研究设计与样本

  • 回顾性队列研究,使用TriNetX研究网络识别自身免疫性肝炎患者。
  • 采用倾向评分匹配,将患者分为维生素D充足(25(OH)D3≥30 ng/mL)、维生素D不足(25(OH)D3 20-29.9 ng/mL)和维生素D缺乏(25(OH)D3<20 ng/mL)组。
  • 共识别1288例维生素D缺乏的自身免疫性肝炎患者,与1288例维生素D正常者进行倾向评分匹配。

主要发现

  • 维生素D缺乏组较维生素D正常组全因死亡比值升高(aOR=3.2,95%CI:2.3-4.48)。
  • 维生素D缺乏组较维生素D正常组全因住院比值升高(aOR=2.37,95%CI:1.97-2.84)。
  • 维生素D缺乏组较维生素D正常组重症监护入院比值升高(aOR=2.8,95%CI:2.21-3.71)。
  • 维生素D缺乏组较维生素D正常组失代偿性肝硬化比值升高(aOR=2.74,95%CI:2.13-3.54)。
  • 维生素D缺乏组较维生素D正常组急性肝衰竭比值升高(aOR=3.11,95%CI:2.09-4.62),肝移植比值升高(aOR=3.47,95%CI:1.71-7.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitamin D deficiency is linked to worse outcomes in patients with chronic liver diseases (CLD). However, data in patients with autoimmune hepatitis (AIH) remain limited. AIMS: We aimed to assess the impact of vitamin D deficiency on the outcomes of individuals with AIH. METHODS: This retrospective cohort study used the TriNetX research network to identify patients with AIH. Patients were matched using propensity score matching and stratified to sufficient vitamin D levels (e.g., 25 (OH) D3 ≥ 30 ng/mL), vitamin D insufficiency (25 (OH) D3: 20-29.9 ng/mL) and vitamin D deficiency (e.g., 25 (OH) D3 < 20 ng/mL). The primary outcome was the all-cause mortality among adult patients with AIH. Secondary outcomes included decompensated liver cirrhosis, acute hepatic failure, liver transplantation (LT), all-cause hospitalizations and all-cause critical care admissions. RESULTS: A total of 1288 AIH patients with vitamin D deficiency were identified and propensity matched with 1288 patients with normal vitamin D levels. Patients with vitamin D deficiency had significantly increased odds for all-cause mortality compared to those with normal levels (adjusted odds ratio (aOR) = 3.2, 95%CI: 2.3-4.48). Patients with vitamin D deficiency were at increased odds of all-cause hospitalizations (aOR = 2.37, 95%CI: 1.97-2.84), critical care unit admissions (aOR = 2.8, 95%CI: 2.21-3.71), decompensated liver cirrhosis (aOR = 2.74, 95%CI: 2.13-3.54), acute hepatic failure (aOR = 3.11, 95%CI: 2.09-4.62) and LT (aOR = 3.47, 95%CI: 1.71-7.04), as compared to those with normal vitamin D levels. CONCLUSION: This cohort study showed significantly increased odds for all-cause mortality in AIH patients with vitamin D deficiency. Vitamin D deficiency in patients with AIH was associated with increased likelihood of hospitalisation, decompensated liver cirrhosis, acute liver failure and LT.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Kilani Y, Alsakarneh S, Madi MY, et al. Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective. Aliment Pharmacol Ther. 2024. PMID: 39660607. doi:10.1111/apt.18438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。